NYSE: UNH
Unitedhealth Group Inc Stock

UNH Price
$322.79
Fair Value Price
N/A
Market Cap
$306.13B
52 Week Low
$194.86
52 Week High
$331.42
P/E
17.92x
P/B
4.81x
P/S
1.13x
PEG
10.59x
Dividend Yield
1.39%
Revenue
$247.81B
Earnings
$17.10B
Gross Profit Margin
26.40%
Operating Margin
9.68%
Net Profit Margin
6.90%
Debt to Equity
1.95
Operating Cash Flow
$22B
Beta
1.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
55
Industry average

Reasons for this score

UNH ($322.79) is trading below its intrinsic value of $465.39, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
UNH is good value based on its earnings relative to its share price (17.92x), compared to the US market average 38.92x)
Valuation
UNH is good value based on its earnings relative to its share price (17.92x), compared to the US Healthcare industry average (18.21x)
Valuation

1 of 13

UNH News

Valuation

UNH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
17.92x
Industry
18.21x
Market
38.92x
UNH is good value based on its earnings relative to its share price (17.92x), compared to the US market average 38.92x)
Valuation
UNH is good value based on its earnings relative to its share price (17.92x), compared to the US Healthcare industry average (18.21x)
Valuation

UNH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.81x
Industry
7.02x
Market
65.04x
UNH is good value based on its book value relative to its share price (4.81x), compared to the US market average (65.04x)
Valuation
UNH is good value based on its book value relative to its share price (4.81x), compared to the US Healthcare industry average (7.02x)
Valuation

UNH price to earnings growth (PEG)

For valuing profitable companies with growth potential
UNH is poor value relative to its rate of earnings growth, measured by PEG ratio (10.59x)
Valuation

UNH's financial health

Profit margin

Revenue
$64.4B
Net Income
$3.4B
Profit Margin
5.20%
UNH's Earnings (EBIT) of $23.99B can safely cover interest payments on company debt ($46.06B)
Financials
UNH's profit margin has increased (+1.40%) in the last year from (5.50%) to (6.90%)
Financials

Assets to liabilities

Assets
$189.1B
Liabilities
$127.5B
Debt to equity
0.91
UNH's short-term liabilities ($69.88B) exceed its short-term assets ($58.92B)
Financials
UNH's short-term assets ($58.92B) exceed its long-term liabilities ($54.24B)
Financials
UNH's debt has increased relative to shareholder equity (1.95), over the past 5 years ago (1.72)
Financials
UNH's debt to equity ratio (1.95) is considered high
Financials

Cash flow

Operating
$2.9B
Investing
-$1.5B
Financing
$9.3B
UNH's operating cash flow ($22.30B) is sufficient to service the company's debt ($46.06B)
Financials

Unitedhealth Group Stock FAQ

(NYSE: UNH) Unitedhealth Group trades on the NYSE under the ticker symbol UNH. Unitedhealth Group stock quotes can also be displayed as NYSE: UNH.
(NYSE: UNH) Unitedhealth Group stock price per share is $322.79 today (as of Oct 21, 2020).
(NYSE: UNH) Unitedhealth Group's 52-week high was $331.42, and its 52-week low was $194.86. It is currently -2.60% from its 52-week high and 65.65% from its 52-week low.
(NYSE: UNH) Unitedhealth Group's market cap is $306.13B, as of Oct 22, 2020.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Unitedhealth Group's market cap is calculated by multiplying UNH's current stock price of $322.79 by UNH's total outstanding shares of 948,379,502.
(NYSE: UNH) Unitedhealth Group currently has 948,379,502 outstanding shares. With Unitedhealth Group stock trading at $322.79 per share, the total value of Unitedhealth Group stock (market capitalization) is $306.13B.

Unitedhealth Group stock was originally listed at a price of $6.21 in Dec 31, 1997. If you had invested in Unitedhealth Group stock at $6.21, your return over the last 22 years would have been 5,097.07%, for an annualized return of 19.67%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics